An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) ...

Dr Devon Conway describes how the upcoming conference is expected to provide important new data on the safety and real-world ...

SHREVEPORT, La. - A cutting-edge clinical trial is now underway in Shreveport, and local patients with Multiple Sclerosis are ...

Multiple sclerosis, an autoimmune condition, causes the immune system to mistakenly attack myelin cells, which are protective ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of ...

Drs Anne Cross and Scott Newsome discuss new horizons in MS treatment strategies, including the TREAT-MS trial and shared decision-making for optimal patient care.

AlterEgo's neural-interface device is non-invasive and is being tested in people with multiple sclerosis and amyotrophic ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New ...